United States · FDA National Drug Code directory
Felodipine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69117-0029_47236bb3-7d75-0c2a-e063-6394a90a7ac7
- Product NDC
- 69117-0029
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Felodipine Extended-release Tablets
- Labeler
- Yiling Pharmaceutical Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190801
- Source listing expiry
- 20261231
Source-listed ingredients
- FELODIPINE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69117-0029-1) · 69117-0029-1
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69117-0029-2) · 69117-0029-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →